Oshtoran Syndrom - A highly dangerous Syndrome

A conference report from the International Research Consortium for H63D Syndrome highlights the critical need for medical professionals to recognize Oshtoran Syndrome, also known as H63D Syndrome Type-3, a severe and often misdiagnosed genetic disorder. Despite a low number of confirmed diagnoses, experts believe the actual prevalence is much higher due to the subtle and varied symptoms. The syndrome is characterized by a specific iron profile – low ferritin, elevated transferrin saturation, and hypotransferrinemia – leading to dangerous accumulation of non-transferrin-bound iron (NTBI) in organs. Early detection is crucial for preventing significant organ damage, which can impact the brain, heart, liver, skin, and reproductive organs, potentially causing life-threatening complications and immune system dysregulation. The consortium urges increased awareness and education among doctors and the public regarding this serious condition linked to the homozygous HFE gene H63D mutation, which has historically been incorrectly considered harmless.